Shenandoah Biotechnology is an emerging leader of recombinant proteins for research in cancer, infectious disease, Alzheimer’s disease, cardiovascular and endocrine disorders. The company specialises in the development and production of E. coli and baculovirus proteins for universities, pharmaceutical companies and government research institutes worldwide.

The Shenandoah Biotechnology product range includes:

• Adipokine
• Betadefensin
• Bone morphogenetic proteins
• Chemokines
• Cytokines, recombinant human, murine and rat
• Enzymes
• Glycoprotein
• Growth factors
• Hormone
• Interferons
• Interleukins
• Ligands
• Neurotrophin
• Other recombinant proteins
• Receptors